SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mohamed Alorabi, Nicole A. Shonka, Apar Kishor Ganti, EGFR monoclonal antibodies in locally advanced head and neck squamous cell carcinoma: What is their current role?, Critical Reviews in Oncology/Hematology, 2016, 99, 170

    CrossRef

  2. 2
    Naomi van der Linden, Jan Buter, Chris P. Pescott, Roy I. Lalisang, Jan Paul de Boer, Alexander de Graeff, Carla M. L. van Herpen, Robert J. Baatenburg de Jong, Carin A. Uyl-de Groot, Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands, European Archives of Oto-Rhino-Laryngology, 2016, 273, 2, 455

    CrossRef

  3. 3
    Emilie A. C. Dronkers, Steven W. Mes, Marjan H. Wieringa, Marc P. van der Schroeff, Robert J. Baatenburg de Jong, Noncompliance to guidelines in head and neck cancer treatment; associated factors for both patient and physician, BMC Cancer, 2015, 15, 1

    CrossRef

  4. 4
    Bengt-Åke Andersson, Freddi Lewin, Jan Lundgren, Mats Nilsson, Lars-Erik Rutqvist, Sture Löfgren, Nongnit Laytragoon-Lewin, Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma, Journal of Cancer Research and Clinical Oncology, 2014, 140, 3, 515

    CrossRef

  5. 5
    Froukje L. J. Cals, Tom C. Bakker Schut, Senada Koljenović, Gerwin J. Puppels, Robert J. Baatenburg Jong, Method development: Raman spectroscopy-based histopathology of oral mucosa, Journal of Raman Spectroscopy, 2013, 44, 7
  6. 6
    Frank R. Datema, Marciano B. Ferrier, Yvonne Vergouwe, Ana Moya, Jan Molenaar, Jay F. Piccirillo, Robert J. Baatenburg de Jong, Update and external validation of a head and neck cancer prognostic model, Head & Neck, 2013, 35, 9